Detalles de la búsqueda
1.
Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease.
Hepatol Res;
2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38661715
2.
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.
Clin Gastroenterol Hepatol;
21(2): 370-379, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35051649
3.
Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease.
Hepatol Res;
53(5): 391-400, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36707103
4.
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large-scale multicenter retrospective study.
Hepatol Res;
53(11): 1059-1072, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37537735
5.
Noninvasive tests predict liver-related events and mortality in patients with nonalcoholic fatty liver disease: sub-analysis of the CLIONE-Asia study.
J Gastroenterol Hepatol;
38(6): 896-904, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36797989
6.
Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learning.
J Gastroenterol Hepatol;
38(10): 1832-1839, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37596843
7.
Association of lysophosphatidic acid molecules with liver fibrosis: different roles indicated.
J Clin Biochem Nutr;
73(3): 255-261, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37970549
8.
Age-dependent effects of diabetes and obesity on liver-related events in non-alcoholic fatty liver disease: Subanalysis of CLIONE in Asia.
J Gastroenterol Hepatol;
37(12): 2313-2320, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36198983
9.
Long-lasting renal dysfunction following tacrolimus induction therapy in ulcerative colitis patients.
J Clin Biochem Nutr;
70(3): 297-303, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35692680
10.
Comparison of dapagliflozin and teneligliptin in nonalcoholic fatty liver disease patients without type 2 diabetes mellitus: a prospective randomized study.
J Clin Biochem Nutr;
68(2): 173-180, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33879970
11.
Prevalence of functional dyspepsia-like symptoms in ulcerative colitis patients in clinical remission and overlap with irritable bowel syndrome-like symptoms.
Scand J Gastroenterol;
55(5): 560-564, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32412797
12.
High expression of a vascular stricture-related marker is predictive of an early response to tolvaptan, and a low fractional excretion of sodium is predictive of a poor long-term survival after tolvaptan administration for liver cirrhosis.
Hepatol Res;
50(12): 1347-1354, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32939957
13.
Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?
Int J Mol Sci;
21(14)2020 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32668632
14.
Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts the development of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.
Hepatol Res;
48(7): 521-528, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29316028
15.
Oral microbiome alterations of healthy volunteers with proton pump inhibitor.
J Gastroenterol Hepatol;
33(5): 1059-1066, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29105152
16.
Effects of Dapagliflozin on Body Composition and Liver Tests in Patients with Nonalcoholic Steatohepatitis Associated with Type 2 Diabetes Mellitus: A Prospective, Open-label, Uncontrolled Study.
Curr Ther Res Clin Exp;
87: 13-19, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28912902
17.
Dynamic ultrasonography for optimizing treatment position in superior mesenteric artery syndrome: Two case reports and review of literature.
World J Gastroenterol;
30(5): 499-508, 2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38414592
18.
Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: A multicenter study in Japan.
Aliment Pharmacol Ther;
59(12): 1559-1570, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38651312
19.
Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study.
Clin Mol Hepatol;
30(2): 225-234, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38263684
20.
Superior mesenteric artery syndrome: Diagnosis and management.
World J Clin Cases;
11(15): 3369-3384, 2023 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37383896